<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to cells is mediated by the cell-surface <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> complex CD11a-c/CD18 and, in some cases, the <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> gp84 </plain></SENT>
<SENT sid="1" pm="."><plain>The process is associated with leukocyte activation and modulates lymphocyte proliferation and maturation </plain></SENT>
<SENT sid="2" pm="."><plain>Epstein-Barr virus (EBV)-transformed <z:mpath ids='MPATH_458'>normal</z:mpath> B lymphocytes give rise to lymphoblastoid cell lines (LCLs) which grow as large clusters mediated by <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, newly explanted EBV-infected Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cells usually grow as single cells or as loose clusters </plain></SENT>
<SENT sid="4" pm="."><plain>We now report that EBV positive- and EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines lack the adhesive protein complex, or have only low levels of it, whereas LCLs, representing various stages of B-lymphocyte development, contain considerably higher amounts, as measured by immunofluorescence flow cytometry and immunoprecipitation </plain></SENT>
<SENT sid="5" pm="."><plain>The level of gp84 expression is of the same magnitude in both types of cells </plain></SENT>
</text></document>